Apparently, tackling Cytoken in AIRDS is an issue and CYK have the capacity to address it but stay their course.
Meanwhile MSB with the same capacity power on.
Not sure with this stock.
Arrogantly stick with the plan or provide a common good?
Opportuniy knocks.
- Forums
- ASX - By Stock
- CYP
- Hopelessly inopportunic
Hopelessly inopportunic
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.29M |
Open | High | Low | Value | Volume |
27.5¢ | 28.0¢ | 27.5¢ | $29.16K | 104.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 30669 | 26.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 44139 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 30669 | 0.265 |
2 | 80839 | 0.260 |
1 | 7698 | 0.255 |
1 | 50000 | 0.250 |
2 | 10000 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 44139 | 1 |
0.290 | 16480 | 1 |
0.295 | 10160 | 1 |
0.305 | 20000 | 1 |
0.310 | 13257 | 2 |
Last trade - 12.47pm 26/06/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |